Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Veradigm Inc. (MDRX : NSDQ)
 
 • Company Description   
Veradigm Inc. is a healthcare technology company which drives value through its combination of platforms, data, expertise, connectivity and scale. Its network features a dynamic community of solutions and partners providing advanced insights, technology and data-driven solutions. Veradigm Inc., formerly known as Allscripts Healthcare Solutions Inc., is based in CHICAGO.

Number of Employees: 8,000

 
 • Price / Volume Information   
Yesterday's Closing Price: $12.89 Daily Weekly Monthly
20 Day Moving Average: 1,564,659 shares
Shares Outstanding: 109.26 (millions)
Market Capitalization: $1,408.36 (millions)
Beta: 1.01
52 Week High: $23.25
52 Week Low: $12.64
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -23.73% -22.50%
12 Week -27.91% -29.72%
Year To Date -26.93% -28.95%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
222 MERCHANDISE MART PLAZA SUITE 2024
-
CHICAGO,IL 60654
USA
ph: 800-334-8534
fax: 313-322-9600
jenny.gelinas@allscripts.com http://www.allscripts.com
 
 • General Corporate Information   
Officers
Paul M. Black - Chief Executive Officer and Director
Michael A. Klayko - Chairman of the Board and Director
Richard J. Poulton - President and Chief Financial Officer
Elizabeth A. Altman - Director
Mara G. Aspinall - Director

Peer Information
Veradigm Inc. (EVOL)
Veradigm Inc. (RAMP)
Veradigm Inc. (ALOT)
Veradigm Inc. (TGHI)
Veradigm Inc. (GNCMA)
Veradigm Inc. (GSIC)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: Technology Services
Sector: Business Services
CUSIP: 01988P108
SIC: 7373
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 09/01/22
Next Expected EPS Date: 03/01/23
Share - Related Items
Shares Outstanding: 109.26
Most Recent Split Date: (:1)
Beta: 1.01
Market Capitalization: $1,408.36 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $0.11 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $0.68 Payout Ratio: 0.00
Number of Estimates in the Fiscal Year Consensus: 5.00 Change In Payout Ratio: 0.00
Estmated Long-Term EPS Growth Rate: 16.00% Last Dividend Paid: NA - $0.00
Next EPS Report Date: 03/01/23  
 

 • Fundamental Ratios
P/E
Current FY Estimate: 18.96
Trailing 12 Months: 11.41
PEG Ratio: 1.18
Price Ratios
Price/Book: 1.21
Price/Cash Flow: 4.68
Price / Sales: 1.68
EPS Growth
vs. Year Ago Period: -4.76%
vs. Previous Quarter: 66.67%
Sales Growth
vs. Year Ago Period: -58.86%
vs. Previous Quarter: 0.66%
ROE
12/31/22 - -
09/30/22 - 10.74
06/30/22 - 10.62
ROA
12/31/22 - -
09/30/22 - 6.68
06/30/22 - 6.31
Current Ratio
12/31/22 - -
09/30/22 - 3.20
06/30/22 - 3.23
Quick Ratio
12/31/22 - -
09/30/22 - 3.20
06/30/22 - 3.23
Operating Margin
12/31/22 - -
09/30/22 - 16.47
06/30/22 - 13.54
Net Margin
12/31/22 - -
09/30/22 - 7.25
06/30/22 - 5.90
Pre-Tax Margin
12/31/22 - -
09/30/22 - 14.59
06/30/22 - 11.84
Book Value
12/31/22 - -
09/30/22 - 10.62
06/30/22 - 10.31
Inventory Turnover
12/31/22 - -
09/30/22 - -
06/30/22 - -
Debt-to-Equity
12/31/22 - -
09/30/22 - 0.17
06/30/22 - 0.17
Debt-to-Capital
12/31/22 - -
09/30/22 - 14.54
06/30/22 - 14.32
 

Powered by Zacks Investment Research ©